FDA-Compliant Medical Device Marketing
One warning letter can force you to pull your entire marketing program overnight. We build medical device marketing that is aggressive enough to win market share and compliant enough to keep your regulatory team comfortable.
INFAB since 2010. AAGL since 2018. Four 2025 Association TRENDY Awards.
Regulatory marketing for medical devices means every claim, testimonial, and comparison is checked against 510(k) clearance language and clinical evidence before it ships, and that the word "approved" never appears when your device is actually cleared. Buzzbox Media has built FDA-compliant marketing programs for medical device companies for over 15 years, embedding regulatory review into content creation from the start so your team spends less time in compliance revision cycles and less time responding to enforcement actions.
Updated June 2026
Key Takeaways
- One FDA warning letter can force you to pull your entire marketing program and demands a formal response within 15 business days.
- The most common error is saying "FDA approved" when a device is actually 510(k) cleared: most Class II devices are cleared, not approved.
- Performance claims like "reduces procedure time by 40%" need published, peer-reviewed clinical data: internal or anecdotal evidence doesn't meet the substantiation standard.
- Comparative superiority claims require head-to-head clinical data; feature comparisons from published specs are fine, "better/superior" without data is not.
- The fix is structural: build regulatory review into content creation from the start, not as an afterthought.
Why Does FDA Compliance Matter in Medical Device Marketing?
FDA enforcement of medical device marketing is not theoretical. Warning letters are issued regularly to companies making unsupported claims, using incorrect regulatory status language, or promoting off-label uses in their marketing materials. The consequences are real: forced removal of content, required corrective advertising, import holds, and in serious cases, consent decrees that put FDA oversight on every piece of promotional material you produce.
Most marketing agencies do not understand these constraints. They write compelling copy that makes claims your 510(k) does not support. They use testimonials that describe off-label use. They design comparison charts that imply superiority without clinical evidence. The marketing looks great, until your regulatory team kills it or, worse, until the FDA notices.
We have spent over 15 years creating marketing for medical device companies. Regulatory awareness is not a service we bolt on. It is embedded in how we create every piece of content, every website, and every campaign.
What Does Regulatory Marketing for Medical Devices Include?
Claims Review Against 510(k) Clearance
Every marketing claim we develop is checked against your device's specific 510(k) clearance letter, indications for use statement, and predicate device history. We identify claims that are supported, claims that need modification, and claims that should not be made. This happens during content creation, not after, which means fewer revision cycles and faster time to market.
Clinical Data Substantiation
When you want to make performance claims, we help determine what your clinical data actually supports. This includes reviewing published studies, internal clinical data, post-market surveillance data, and adverse event history. We draft claims that maximize marketing impact within the boundaries of your evidence base.
Comparative Advertising Compliance
Comparison to competitors is one of the most effective marketing tactics, and one of the most regulated. We develop comparative content that uses published specifications, peer-reviewed clinical data, and cleared claims only. No implied superiority without evidence. No cherry-picked data points. Comparisons that are defensible if challenged by a competitor or regulator. Our guide to comparative advertising for medical devices walks through the FDA and Lanham Act rules that decide which comparisons hold up.
Promotional Material Review
We review existing marketing materials (websites, brochures, sell sheets, presentations, social media, trade show materials) for potential regulatory issues. The audit identifies specific problems, prioritizes them by risk level, and provides recommended corrections for each item. Many clients are surprised by what they find in materials they have been using for years.
What Are the Most Common FDA Marketing Violations?
These errors trigger FDA enforcement actions regularly
We see these issues in the majority of medical device marketing materials we audit. Each one represents a potential regulatory risk.
- Using "FDA approved" when the device is 510(k) cleared. These are different regulatory pathways with different legal meanings. Most Class II devices are cleared, not approved. Getting this wrong undermines your credibility with regulators and sophisticated buyers alike.
- Making performance claims without adequate clinical evidence. Statements like "reduces procedure time by 40%" require published, peer-reviewed clinical data specific to your device. Internal data or anecdotal surgeon feedback does not meet the substantiation standard.
- Surgeon testimonials that describe off-label use. If a KOL describes using your device for an indication not covered by your 510(k) clearance, that testimonial is promoting off-label use regardless of who wrote the script.
- Omitting required information from promotional materials. Product brochures and advertisements must include indications for use, relevant contraindications, and a brief summary of warnings and precautions. Omitting these is a common violation.
- Making superiority claims in competitive comparisons. Claiming your device is "better" or "superior" requires head-to-head clinical data. Feature comparisons based on published specifications are allowed; performance superiority claims without data are not.
What Is the Difference Between FDA Cleared and FDA Approved in Marketing Copy?
This is the single most common error we see in medical device marketing, and it matters more than most companies realize. The 510(k) pathway (clearance) demonstrates substantial equivalence to a predicate device. The PMA pathway (approval) requires clinical trials demonstrating safety and efficacy. Using the wrong term is not just technically incorrect. It misrepresents your device's regulatory status to buyers, which is exactly the kind of issue that triggers FDA enforcement.
Beyond compliance, sophisticated buyers (hospital procurement teams, GPO evaluators, and experienced surgeons) notice when you get this wrong. It signals that your marketing team does not understand the regulatory landscape, which raises questions about what else you might be getting wrong.
We build the correct regulatory language into every piece of content we create, and we check existing materials for this error in every audit.
Selling a medical device? Book a free 30‑minute call with Baron.
Frequently Asked Questions
What is the difference between FDA cleared and FDA approved?
FDA cleared means a device has gone through the 510(k) premarket notification process, demonstrating substantial equivalence to a legally marketed predicate device. FDA approved means a device has gone through the more rigorous Premarket Approval (PMA) process with clinical trials demonstrating safety and efficacy. Most Class II medical devices are 510(k) cleared, not approved. Using "FDA approved" when your device is actually 510(k) cleared is a common marketing error that can trigger FDA enforcement action. Your marketing materials should use the correct term for your device's regulatory pathway.
Can we use surgeon testimonials in our medical device marketing?
Yes, but with specific constraints. Surgeon testimonials must reflect the device's cleared indications for use. A testimonial cannot describe off-label use, make comparative superiority claims without clinical data, or imply outcomes beyond what your clinical evidence supports. Testimonials from paid consultants should include appropriate disclosure. We structure testimonial programs to capture compelling surgeon perspectives while staying within FDA promotional guidelines.
How do I know if our current marketing materials are FDA compliant?
We offer marketing material audits where we review your existing promotional content against your 510(k) clearance, available clinical data, and current FDA guidance documents. We check for common issues: off-label claims, unsubstantiated performance comparisons, misuse of regulatory status language, and missing required disclosures. The audit produces a prioritized report of issues with specific recommendations for each piece of content.
What happens if FDA sends a warning letter about our marketing?
An FDA warning letter requires a formal response within 15 business days. The immediate priority is removing or correcting the violative materials. This can mean pulling website content, brochures, social media posts, and any other promotional materials cited in the letter. Beyond the immediate response, you need to review all remaining marketing materials for similar issues and implement a compliant review process going forward. Prevention is far less expensive than remediation, which is why we build regulatory review into the content creation process from the start.
Related Services
- Medical Device MarketingFull-service marketing strategy with regulatory compliance built in from the start.
- Content MarketingClinically accurate content with multi-stage regulatory review baked into the production process.
- Medical Device BrandingBrand messaging frameworks aligned with 510(k) clearance language and clinical positioning.